| Investor | Value | Of portfolio | Shares | Change | Quarter |
|---|---|---|---|---|---|
| Renaissance Technologies | $656.6K | 0.00% | 23.34K | −69% | Q2 2026 |
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a ALMS trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 7, 2026 | Akkaraju SrinivasDirector | Sale at price 10.55 per share. | 96.1K | $1.01M |
| Sep 7, 2026 | Akkaraju SrinivasDirector | Purchase at price 10.63 - 11.17 per share. | 986.7K | $10.73M |
| Aug 2, 2026 | Hardiman Roy CharlesOfficer | Sale at price 26.37 per share. | 2.7K | $70.99K |
| Aug 2, 2026 | Schroer John RChief Financial Officer | Sale at price 26.37 per share. | 3.3K | $86.55K |
| Aug 2, 2026 | Goldstein David M Ph.D.Officer | Sale at price 26.37 per share. | 2.6K | $68.46K |
| Aug 2, 2026 | Drappa JornOfficer | Sale at price 26.37 per share. | 2.4K | $64.53K |
| Aug 2, 2026 | Pangali SanamOfficer | Sale at price 26.37 per share. | 1.4K | $35.97K |
| Aug 2, 2026 | Bradley Mark ChristopherOfficer | Sale at price 26.37 per share. | 2.6K | $67.82K |
| Jul 5, 2026 | Pangali SanamOfficer | Sale at price 28.00 per share. | 5K | $140.00K |
| Jul 5, 2026 | Pangali SanamOfficer | Conversion of Exercise of derivative security at price 5.06 per share. | 5K | $25.30K |
| Jun 29, 2026 | Yao ZhengbinDirector | Stock Award(Grant) at price 0.00 per share. | 3.6K | — |
| Jun 29, 2026 | Srivastava SapnaDirector | Stock Award(Grant) at price 0.00 per share. | 3.6K | — |
| Jun 29, 2026 | Tetrault Lynn A.Director | Stock Award(Grant) at price 0.00 per share. | 3.6K | — |
| Jun 29, 2026 | Machado PatrickDirector | Stock Award(Grant) at price 0.00 per share. | 3.6K | — |
| Jun 29, 2026 | Akkaraju SrinivasDirector | Stock Award(Grant) at price 0.00 per share. | 3.6K | — |
| May 21, 2026 | Drappa JornOfficer | Conversion of Exercise of derivative security at price 5.06 - 8.84 per share. | 26.9K | $178.65K |
| Jan 8, 2026 | Akkaraju SrinivasDirector | Purchase at price 17.00 per share. | 588.2K | $10.00M |
| Jan 7, 2026 | Tananbaum James BDirector and Beneficial Owner of more than 10% of a Class of Security | Purchase at price 17.00 per share. | 411.8K | $7.00M |
| Jan 7, 2026 | Foresite Capital Management Vi, Llc.Beneficial Owner of more than 10% of a Class of Security | Purchase at price 17.00 per share. | 411.8K | $7.00M |
| Dec 4, 2025 | Akkaraju SrinivasDirector | Purchase at price 8.95 - 10.73 per share. | 186.4K | $1.83M |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 151.1 | 21.1 | -25.8 | 12.1 | -12.5 | 30.3 | 0.4 | -22.8 | -66.1 | -11.2 | −32.8% | ||
| 2025 | -4.8 | -37.8 | 32.0 | -32.6 | -15.5 | -14.3 | 38.0 | 12.1 | -14.0 | 19.0 | 61.5 | 27.2 | +24.2% |
| 2024 | -7.5 | 3.3 | -15.9 | 6.0 | -18.2 | -15.1 | −40.9% |
Alumis Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of medicines for autoimmune disorders. The company offers envudeucitinib, a tyrosine kinase 2 (TYK2) inhibitor for the treatment of plaque psoriasis and systemic lupus erythematosus; and A-005, a central nervous system-penetrant allosteric TYK2 inhibitor that is in Phase 1 for the treatment of neuroinflammatory and neurodegenerative diseases. It also develops lonigutamab, a monoclonal antibody targeting IGF-1R for the treatment of thyroid eye diseases; and interferon regulatory factor 5 (IRF5) to address immune dysfunction. The company was formerly known as Esker Therapeutics, Inc. and changed its name to Alumis Inc. in January 2022. Alumis Inc. was incorporated in 2021 and is headquartered in South San Francisco, California.
Buy / hold / sell counts